News + Filings Holdings
|
VICTORY CAPITAL MANAGEMENT INC
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 564,355 | -34,330 | 14,283,825,000 | -4,999,819,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 598,685 | 567,555 | 19,283,644,000 | 18,708,984,000 | $32,210.00 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | 31,130 | -9,410 | 574,660,000 | 573,566,000 | $18,460.01 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 40,540 | 40,540 | 1,094,000 | 1,094,000 | $26.99 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 0 | -9,482 | 0 | -264,000 | |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 9,482 | -436 | 264,000 | -30,000 | $27.84 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 9,918 | -284 | 294,000 | 9,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 10,202 | 391 | 285,000 | 7,000 | $27.94 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 9,811 | 483 | 278,000 | 43,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 9,328 | 9,328 | 235,000 | 235,000 | $25.19 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 0 | -7,983 | 0 | -118,000 | |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 7,983 | -1,864 | 118,000 | -42,000 | $14.78 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 9,847 | 3,508 | 160,000 | 78,000 | $16.25 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 6,339 | 6,339 | 82,000 | 82,000 | $12.94 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 0 | -59,245 | 0 | -1,626,000 | |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 59,245 | -3,300 | 1,626,000 | -300,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 62,545 | 6,860 | 1,926,000 | -65,000 | $30.79 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 55,685 | 20,970 | 1,991,000 | 1,035,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 34,715 | -160 | 956,000 | 35,000 | $27.54 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 34,875 | -650 | 921,000 | 182,000 | $26.41 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 35,525 | 35,525 | 739,000 | 739,000 | $20.80 |
| << Prev Next >> |
|